Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 245253, 8 pages
http://dx.doi.org/10.1155/2013/245253
Clinical Study

The Role of Xanthine Oxidase in Hemodialysis-Induced Oxidative Injury: Relationship with Nutritional Status

1Institute of Biochemistry, Medical Faculty Pristina, 38220 Kosovska Mitrovica, Serbia
2Internal Clinic, Medical Faculty Pristina, 38220 Kosovska Mitrovica, Serbia
3Department of Informatics, State University of Novi Pazar, 36300 Novi Pazar, Serbia
4Institute of Pharmacology, Medical Faculty Pristina, 38220 Kosovska Mitrovica, Serbia

Received 31 January 2013; Accepted 17 May 2013

Academic Editor: Kota V. Ramana

Copyright © 2013 Dijana Miric et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Kalantar-Zadeh and V. S. Balakrishnan, “The kidney disease wasting: inflammation, oxidative stress, and diet-gene interaction,” Hemodialysis International, vol. 10, no. 4, pp. 315–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Capeillère-Blandin, V. Gausson, A. T. Nguyen, B. Descamps-Latscha, T. Drüeke, and V. Witko-Sarsat, “Respective role of uraemic toxins and myeloperoxidase in the uraemic state,” Nephrology Dialysis Transplantation, vol. 21, no. 6, pp. 1555–1563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Kobayashi, E. Ishimura, Y. Kato et al., “Geriatric Nutritional Risk Index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients,” Nephrology Dialysis Transplantation, vol. 25, no. 10, pp. 3361–3365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Honda, M. Ueda, S. Kojima et al., “Assessment of myeloperoxidase and oxidative a1-antitrypsin in patients on hemodialysis,” Clinical Journal of the American Society of Nephrology, vol. 4, pp. 142–151, 2009. View at Google Scholar
  5. H. Honda, M. Ueda, S. Kojima et al., “Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 5, pp. 1021–1028, 2010. View at Google Scholar
  6. U. R. Kuppusamy, M. Indran, T. Ahmad, S. W. Wong, S. Y. Tan, and A. A. Mahmood, “Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus,” Clinica Chimica Acta, vol. 351, no. 1-2, pp. 197–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Obara, A. Hirayama, M. Gotoh et al., “Elimination of lipid peroxide during hemodialysis,” Nephron Clinical Practice, vol. 106, pp. c162–c168, 2007. View at Google Scholar
  8. S. Gibbings, N. D. Elkins, H. Fitzgerald et al., “Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-γ sumoylation, and HIF-1α,” Journal of Biological Chemistry, vol. 286, no. 2, pp. 961–975, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Pacher, A. Nivorozhkin, and C. Szabó, “Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol,” Pharmacological Reviews, vol. 58, no. 1, pp. 87–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Houston, A. Estevez, P. Chumley et al., “Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling,” Journal of Biological Chemistry, vol. 274, no. 8, pp. 4985–4994, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Gwinner, H. Scheuer, H. Haller, R. P. Brandes, and H. Groene, “Pivotal role of xanthine oxidase in the initiation of tubulointerstitial renal injury in rats with hyperlipidemia,” Kidney International, vol. 69, no. 3, pp. 481–487, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Kushiyama, H. Okubo, H. Sakoda et al., “Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, pp. 291–298, 2012. View at Google Scholar
  13. J. Y. Choi, Y. J. Yoon, H. J. Choi et al., “Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients undergoing hemodialysis,” Nephrology Dialysis Transplantation, vol. 26, pp. 1304–1313, 2011. View at Google Scholar
  14. J. Springer, A. Tschimer, K. Hartman et al., “Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia,” International Journal of Cancer, vol. 131, pp. 2187–2196, 2012. View at Google Scholar
  15. G. G. Roussos, “Xanthine oxidase from bovine small intestine,” Methods in Enzymology, vol. 12, pp. 5–16, 1967. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Metcalf, J. I. Gallin, W. M. Nauseef, and R. K. Root, “Myeloperoxidase functional assays,” in Laboratory Manual of Neutrophil Function, pp. 150–151, Raven Press, New York, NY, USA, 1986. View at Google Scholar
  17. H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase,” Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at Google Scholar · View at Scopus
  18. E. Beutler, O. Duron, and B. M. Kelly, “Improved method for the determination of blood glutathione,” The Journal of Laboratory and Clinical Medicine, vol. 61, pp. 882–888, 1963. View at Google Scholar · View at Scopus
  19. J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, K. L. E. Ling, and S. P. Wolff, “Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma: relevance to determination of total plasma lipid hydroperoxide concentrations,” Biochemical Journal, vol. 313, no. 3, pp. 781–786, 1996. View at Google Scholar · View at Scopus
  20. B. Anderstam, B. Ann-Christin, A. Valli, P. Stenvinkel, B. Lindholm, and M. E. Suliman, “Modification of the oxidative stress biomarker AOPP assay: application in uremic samples,” Clinica Chimica Acta, vol. 393, no. 2, pp. 114–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Dobiášová and J. Frohlich, “The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL),” Clinical Biochemistry, vol. 34, no. 7, pp. 583–588, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. J. K. Leypoldt, A. K. Cheung, J. A. Delmez et al., “Relationship between volume status and blood pressure during chronic hemodialysis,” Kidney International, vol. 61, no. 1, pp. 266–275, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Landmesser, S. Spiekermann, S. Dikalov et al., “Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase,” Circulation, vol. 106, no. 24, pp. 3073–3078, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Radi, K. M. Bush, T. P. Cosgrove, and B. A. Freeman, “Reaction of xanthine oxidase-derived oxidants with lipid and protein of human plasma,” Archives of Biochemistry and Biophysics, vol. 286, no. 1, pp. 117–125, 1991. View at Google Scholar · View at Scopus
  25. V. Witko-Sarsat, M. Friedlander, N. T. Khoa et al., “Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure,” Journal of Immunology, vol. 161, pp. 2524–2532, 1998. View at Google Scholar
  26. Ş. Demirci, M. R. Şekeroǧlu, T. Noyan et al., “The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis,” Cell Biochemistry and Function, vol. 29, no. 3, pp. 249–254, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Ohtsubo, I. I. Rovira, M. F. Starost, C. Liu, and T. Finkel, “Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2,” Circulation Research, vol. 95, no. 11, pp. 1118–1124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. H. J. Moshage, J. A. M. Janssen, and J. H. Franssen, “Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation,” Journal of Clinical Investigation, vol. 79, no. 6, pp. 1635–1641, 1987. View at Google Scholar · View at Scopus
  29. J. S. McNally, M. E. Davis, D. P. Giddens et al., “Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress,” American Journal of Physiology, vol. 285, no. 6, pp. H2290–H2297, 2003. View at Google Scholar · View at Scopus
  30. W. L. Biffl and E. E. Moore, “Splanchnic ischaemia/reperfusion and multiple organ failure,” British Journal of Anaesthesia, vol. 77, no. 1, pp. 59–70, 1996. View at Google Scholar · View at Scopus
  31. F. Derbre, B. Ferrando, M. C. Gomez-Cabrera et al., “Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases,” PloS ONE, vol. 7, Article ID e46668, 2012. View at Publisher · View at Google Scholar
  32. F. Wang, H. Jiang, K. Shi, Y. Ren, P. Zhang, and S. Cheng, “Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients,” Nephrology, vol. 17, pp. 733–738, 2012. View at Google Scholar